Top compounds associated with response to LRRC15


Feature Type Standardized
Nominal ANOVA
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC -0.083 0.004
mRNA PF-4800567 hydrochloride CTRPv2 pan-cancer AAC 0.16 0.005
mRNA BRD-K11533227 CTRPv2 pan-cancer AAC 0.1 0.005
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.1 0.006
mRNA Talazoparib GDSC1000 pan-cancer AAC -0.092 0.006
mRNA KHS101 CTRPv2 pan-cancer AAC -0.1 0.007
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.095 0.008
mRNA BRD-K71935468 CTRPv2 pan-cancer AAC 0.1 0.008
mRNA 17-AAG GDSC1000 pan-cancer AAC 0.085 0.008
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.008
Download CSV